Rosato Roberto R
Virginia Commonwealth University, Massey Cancer Center, 401 College Street, PO Box 980037, Richmond, VA 23298-0037, USA.
IDrugs. 2010 Jan;13(1):13-5.
The HDAC Inhibitors meeting, held in Boston, included topics covering new therapeutic developments in the field of HDAC inhibitors. This conference report highlights selected presentations on HDAC inhibitors for the treatment of cancer, inflammation, and neurodegenerative and other CNS diseases. Investigational drugs discussed include several compounds under evaluation by Karus Therapeutics Ltd, OCID-4681 (Orchid Research Laboratories Ltd) and EVP-0334 (EnVivo Pharmaceuticals Inc).
在波士顿举行的组蛋白去乙酰化酶（HDAC）抑制剂会议涵盖了HDAC抑制剂领域新治疗进展的相关主题。本会议报告重点介绍了关于HDAC抑制剂用于治疗癌症、炎症、神经退行性疾病及其他中枢神经系统疾病的部分演讲内容。所讨论的在研药物包括Karus Therapeutics有限公司正在评估的几种化合物、OCID - 4681（Orchid Research Laboratories有限公司）和EVP - 0334（EnVivo Pharmaceuticals公司）。
Zotero 插件